Your browser doesn't support javascript.
loading
GPAT3 is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma.
Zhou, Yu; Zhao, Huakan; Ren, Ran; Zhou, Mingyue; Zhang, Jiangang; Wu, Zhijuan; Chen, Yu; Lei, Juan; Chen, Yang; Yu, Ying; Li, Yongsheng.
Afiliação
  • Zhou Y; Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing 400030, China.
  • Zhao H; College of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China.
  • Ren R; Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing 400030, China.
  • Zhou M; Chongqing University Cancer Hospital, School of Medicine, Chongqing University, Chongqing 400044, China.
  • Zhang J; Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing 400030, China.
  • Wu Z; Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing 400030, China.
  • Chen Y; Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing 400030, China.
  • Lei J; Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing 400030, China.
  • Chen Y; Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing 400030, China.
  • Yu Y; Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing 400030, China.
  • Li Y; College of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China.
Theranostics ; 14(9): 3470-3485, 2024.
Article em En | MEDLINE | ID: mdl-38948063
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Resistencia a Medicamentos Antineoplásicos / Fator de Transcrição STAT3 / Sorafenibe / Neoplasias Hepáticas Limite: Animals / Humans Idioma: En Revista: Theranostics Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Resistencia a Medicamentos Antineoplásicos / Fator de Transcrição STAT3 / Sorafenibe / Neoplasias Hepáticas Limite: Animals / Humans Idioma: En Revista: Theranostics Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China